CD274 and neoplasm: Even though we could not rule out the possibility that anti-PD-L1 antibody treatments promote immune cell tumor infiltration and simultaneously exert antibody-dependent cell-mediated cytotoxicity on PD-L1+ immune cells, the exact underlying mechanism requires further investigation.